Hong Nguyen, MD
Procedural Dermatology · Long Beach, CANPI 1295022259
Payments from drug & device makers
Across 647 payments — averaging $21.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Sanofi$2K
- Journey Medical Corporation$1K
- LEO Pharma Inc.$942
- Johnson & Johnson$939
- Novartis$905
- plus $6K from 32 others
What the payments were for
- Consulting fees$1,0007%
- Food & beverage$12,87092%
- Education$1331%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 130 | $2,588 |
| Sanofi | 39 | $1,547 |
| Journey Medical Corporation | 4 | $1,060 |
| LEO Pharma Inc. | 38 | $942 |
| Johnson & Johnson | 38 | $939 |
| Novartis | 38 | $905 |
| Regeneron Healthcare Solutions, Inc. | 27 | $823 |
| UCB, Inc. | 124 | $701 |
| Lilly USA, LLC | 27 | $631 |
| Pfizer | 36 | $525 |
| Amgen | 14 | $406 |
| Galderma Laboratories, L.p. | 21 | $374 |
| Incyte Corporation | 14 | $362 |
| Sun Pharmaceutical Industries Inc. | 13 | $348 |
| Boehringer Ingelheim | 9 | $260 |
| Almirall LLC | 10 | $205 |
| E.r. Squibb & Sons, L.L.C. | 6 | $169 |
| Mayne Pharma Commercial LLC | 7 | $148 |
| Genentech USA, Inc. | 12 | $144 |
| Dermavant Sciences, Inc. | 3 | $136 |
| Biofrontera Inc. | 5 | $107 |
| Arcutis Biotherapeutics, Inc. | 5 | $89 |
| Blueprint Medicines Corporation | 2 | $65 |
| Verrica Pharmaceuticals Inc. | 2 | $62 |
| Kyowa Kirin, Inc. | 2 | $50 |
| Merz North America, Inc. | 2 | $50 |
| Botanix SB Inc | 2 | $46 |
| Fresenius Kabi USA, LLC | 2 | $45 |
| Solta Medical, A Division Of Bausch Health US, LLC | 2 | $41 |
| Helsinn Therapeutics (U.S.), Inc. | 2 | $34 |
| Prugen, Inc. Pharmaceuticals | 3 | $33 |
| Sandoz | 1 | $27 |
| Lifenet Health | 1 | $26 |
| Aclaris Therapeutics, Inc. | 1 | $25 |
| Organon | 2 | $25 |
| LNHC, Inc | 1 | $24 |
| DUSA Pharmaceuticals, Inc. | 1 | $24 |
| VYNE Pharmaceuticals Inc. | 1 | $17 |
How this compares
$14,003 in reported general payments places this provider in the 75th percentile of 108 procedural dermatology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 103 | $5,708 |
| Tacrolimus | 29 | $4,465 |
| Calcipotriene | 25 | $3,661 |
| Metronidazole | 94 | $3,591 |
| Fluocinonide | 63 | $2,713 |
| Ketoconazole | 160 | $2,427 |
| Fluorouracil | 31 | $1,988 |
| Triamcinolone Acetonide | 190 | $1,735 |
| Doxycycline Hyclate | 63 | $1,453 |
| Clindamycin Phosphate | 49 | $1,127 |
| CiclopiroxCiclopirox Olamine | 40 | $956 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 38 | $922 |
| Tretinoin | 20 | $866 |
| Econazole Nitrate | 34 | $629 |
| ValacyclovirValacyclovir Hcl | 26 | $584 |
Paid to pharmacies, not to this prescriber.
Other procedural dermatology in Long Beach
- Hadas SkupskyLong Beach$6K
- Bryna KaneLong Beach$3K
- Sabrina FabiSan Diego$6.8M
- Natasha MesinkovskaMission Viejo$4M
- Sam Khalifianla Mesa$3.6M
- Mitchel GoldmanSan Diego$1.5M
- Jeanette BlackLos Angeles$492K
- Suzanne KilmerSacramento$475K
- Rebecca FitzgeraldLos Angeles$324K
- Aram KechichianSanta Clarita$300K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.